Ledger.Open graph →

SEC Form D · Amendment · filed May 11, 2022

Phoreus Biotechnology, Inc

Offering

$3.0M

Sold

$1.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

OLATHE, KS

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael Coe · Perry, KSExec · Director Randall Tosh · Olathe, KSExec · Director Matthew Tomich · Seattle, WADirector Rajeet Pannu · New York, NYDirector Ankit Khandelwal · Naperville, ILExec · Director David Sze · San Francisco, CAExec · Director Lynn Rundle · Palm Beach Gardens, FLDirector Bradley Holliday · Kansas City, MODirector Nathan Singh · Saint Louis, MODirector Matthew Tomich · Seattle, WADirector Rajeet Pannu · New York, NYDirector Daniel Motto · Princeton, NJExec · Director Joseph Moye · Orlando, FLExec · Director Andrew Ferrier · Coral Gables, FLDirector Francoise Duboc · Coral Gables, FLDirector Lynn Rundle · Palm Beach Gardens, FLDirector Bradley Holliday · Kansas City, MODirector Nathan Singh · Saint Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗